RMIT Drug Discovery Technologies

RMIT Drug Discovery Technologies Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

RMIT Drug Discovery Technologies General Information

Description

Provider of pre-clinical safety toxicology and bio-analytical services. The company's activities include genetic toxicity, mammalian toxicity, safety pharmacology, drug metabolism and pharmacokinetics and pathology services, enabling drug discovery and development industry to innovate and discover unique drugs for the treatment of chronic diseases.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Primary Office
  • PO Box 71
  • Bundoora, Victoria 3083
  • Australia
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RMIT Drug Discovery Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RMIT Drug Discovery Technologies‘s full profile, request access.

Request a free trial

RMIT Drug Discovery Technologies Executive Team (1)

Name Title Board Seat Contact Info
Frances Guyett Chief Executive Officer

RMIT Drug Discovery Technologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore RMIT Drug Discovery Technologies‘s full profile, request access.

Request a free trial